Thomas M. Grogan
- Oncology top 0.2%
- Pathology and Forensic Medicine top 0.1%
- Molecular Biology top 2%
- Genetics top 0.5%
- Hematology top 0.5%
- Co-authors
- Thomas P. MillerCatherine SpierWilliam BellamyY FrutigerWilliam S. DaltonTP MillerL RichterRichard I. Fisher
- Topics
- Lymphoma Diagnosis and Treatment (66 papers)Chronic Lymphocytic Leukemia Research (30 papers)Monoclonal and Polyclonal Antibodies Research (25 papers)
- Journals
- New England Journal of MedicineJournal of Clinical InvestigationJournal of Clinical Oncology
- Partner nations
- United StatesCanadaSpain
In The Last Decade
Thomas M. Grogan
154 papers receiving 8.8k citations
Hit Papers
Peers
Comparison fields: 5 of 125
- Oncology 5.0k
- Pathology and Forensic Medicine 3.4k
- Molecular Biology 3.1k
- Genetics 1.4k
- Hematology 1.2k
Countries citing papers authored by Thomas M. Grogan
This map shows the geographic impact of Thomas M. Grogan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas M. Grogan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas M. Grogan more than expected).
Fields of papers citing papers by Thomas M. Grogan
This network shows the impact of papers produced by Thomas M. Grogan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas M. Grogan. The network helps show where Thomas M. Grogan may publish in the future.
Co-authorship network of co-authors of Thomas M. Grogan
This figure shows the co-authorship network connecting the top 25 collaborators of Thomas M. Grogan. A scholar is included among the top collaborators of Thomas M. Grogan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas M. Grogan. Thomas M. Grogan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 42 | |
| 3 | 108 | |
| 4 | 5 | |
| 5 | 23 | |
| 6 | 2 | |
| 7 | P1-07 Automated Colormetric Tyramide Signal Amplification In Situ Hybridization (TISH) Detection of Single HER-2/neu Oncogene Copies | 1 |
| 8 | New REAL clinical entities. | 9 |
| 9 | Expression of p53 protein in actinic keratosis, adjacent, normal-appearing, and non-sun-exposed human skin. | 44 |
| 10 | 62 | |
| 11 | 140 | |
| 12 | 2 | |
| 13 | 374 | |
| 14 | 2 | |
| 15 | 16 | |
| 16 | 178 | |
| 17 | 55 | |
| 18 | Clonal ambiguity of human immunodeficiency virus-associated lymphomas. Similarity to posttransplant lymphomas. | 19 |
| 19 | 82 | |
| 20 | 29 |
About Thomas M. Grogan
Thomas M. Grogan is a scholar working on Pathology and Forensic Medicine, Genetics and Oncology, having authored 160 papers that have together received 9.2k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (66 papers), Chronic Lymphocytic Leukemia Research (30 papers) and Monoclonal and Polyclonal Antibodies Research (25 papers). The work is most often cited by research in Pathology and Forensic Medicine (3.4k citations), Oncology (5.0k citations) and Genetics (1.4k citations). Thomas M. Grogan has collaborated with scholars based in United States, Canada and Spain. Frequent co-authors include Thomas P. Miller, Catherine Spier, William Bellamy, Y Frutiger, William S. Dalton, TP Miller, L Richter, Richard I. Fisher, Michael LeBlanc and Roger A. Warnke. Their work appears in journals such as New England Journal of Medicine, Journal of Clinical Investigation and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.